Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook-square
  • x
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > News & Updates > Regulatory Updates > Drugs > Minutes of 359th Meeting of the Registration Board (09 June 2026)

Minutes of 359th Meeting of the Registration Board (09 June 2026)

Mughees Mudassir Drugs, Registration Board July 27, 2026July 27, 2026DRAP, Drugs, PER, Registartions

Minutes of 359th Meeting of the Registration Board

https://www.dra.gov.pk/wp-content/uploads/2026/07/Minues-of-359th-meeting-of-Registration-Board-2.pdf

Share this:

  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • ← Mandatory Requirement of Auditor’s Report Bearing UDIN for Issuance of Nothing Due Certificate (NDC) in Respect of Central Research Fund
  • Minutes of 360th Meeting of the Registration Board (07 July 2026) →
  • Guidelines
    • Pharmaceuticals
    • Biologicals
    • Medical Devices
    • Alternative Medicines & Health Products
    • Pharmacy Services
    • Pharmacovigilance
    • Quality Assurance
  • Newsletters
  • Regulatory Procedures
  • Regulatory Fees
  • Application Forms
  • Public Consultations
    • Invitation for Comments
    • About Consultations
    • How to Submit Comments
  • Minutes of the Meetings
    • Registration Board
    • Central Licensing Board
    • Medical Devices Board
    • Enlistment Evaluation Committee
    • Clinical Studies Committee
    • Pharmacovigilance RAE Committee
  • Drugs
  • Medical Devices
  • Alternative Medicines
  • Controlled Substances
  • Licensing and Inspections
  • Clinical Trials
  • Pharmacovigilance
  • Advertisements
  • General

Quick Navigation

     
  • Registered Drugs Index
  • Drug Pricing Index
  • List of Pharmaceutical Units

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem